Table 2. Comparison of the antibiotic usage during the last 3 months in the study population with and without ESBL positive Escherichia coli and Klebsiella species.
| Antibiotics | ESBL (+) (n=66) | ESBL (−) (n=112) | p-value | OR (95% CI) |
|---|---|---|---|---|
| Penicillins | 0 (0.0) | 11 (9.8) | >0.05 | 1.65 (1.460–1.860) |
| Fluoroquinolones | 19 (28.8) | 18 (16.1) | <0.05 | 2.11 (1.010–4.397) |
| Cephalosporins | 5 (7.6) | 4 (3.6) | >0.05 | 2.21 (0.570–8.550) |
| Fosfomycin | 2 (3.0) | 3 (2.7) | >0.05 | 1.13 (0.180–6.970) |
| Nitrofurantoin | 7 (10.6) | 2 (1.8) | <0.05 | 6.50 (1.314–32.400) |
Values are presented as number (%).
ESBL, extended-spectrum β-lactamase; OR, odds ratio; CI, confidence interval.